natgillin/translations-raw huggingface dataset:
Reproduction is authorised provided the source is acknowledged. risikoen for infektioner i yveret, der kan føre til yverbetændelse.
Reproduction is authorised provided the source is acknowledged. giving Imrestor, the number of neutrophils in the blood is increased, which is an aid to reduce the risk of infections of the udder that might lead to mastitis.
Reproduction is authorised provided the source is acknowledged. salbutamol (som alle er beta-agonister, en anden gruppe lægemidler, der anvendes ved truende for tidlig fødsel).
Reproduction is authorised provided the source is acknowledged. from a different class of medicines used in pre-term labour called beta-agonists).
Reproduction is authorised provided the source is acknowledged. sammen.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. samtidigt), gives to doser med et interval på mindst to måneder, efterfulgt af en booster ved 11- 15-måneders alderen.
Reproduction is authorised provided the source is acknowledged. at around the same time), two doses can be given with an interval of at least two months, followed by a booster at 11 to 15 months of age.
Reproduction is authorised provided the source is acknowledged. sekunder efter natriumchloridindsprøjtningen.
Reproduction is authorised provided the source is acknowledged. after the sodium chloride injection.
Reproduction is authorised provided the source is acknowledged. selv kan give injektionerne, når de først er blevet behørigt instrueret heri.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. sidste dosis mindst to uger før den forventede faring.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. skizoaffektiv lidelse.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. skjoldbruskkirtelvævet på en scanning.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. skrumper ind, bevirker den stærke vedhæftning, at nethinden udsættes for en trækbelastning.
Reproduction is authorised provided the source is acknowledged. eye).
Reproduction is authorised provided the source is acknowledged. slim, der holder skeden fugtig.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. smertelindring og eventuelle bivirkninger.
Reproduction is authorised provided the source is acknowledged. possible side effects.
Reproduction is authorised provided the source is acknowledged. som har sekundær progressiv dissemineret sklerose (den form for dissemineret sklerose, der følger efter relapsing-remitterende dissemineret sklerose), når sygdommen er aktiv.
Reproduction is authorised provided the source is acknowledged. who have secondary progressive MS (the type of MS that comes after relapsing-remitting MS), when their disease is active.
Reproduction is authorised provided the source is acknowledged. sulfonylurinstof eller insulin, kan en lavere dosis af sulfonylurinstoffet eller insulinet overvejes, da der er risiko for hypoglykæmi (lavt blodsukker).
Reproduction is authorised provided the source is acknowledged. dose of the sulphonylurea or insulin may be considered because of the risk of hypoglycaemia (low blood sugar).
Reproduction is authorised provided the source is acknowledged. supplerende, længere undersøgelse med deltagelse af over 3 000 adipøse patienter sammenlignede virkningerne af Xenical og placebo over en periode på fire år i kombination med diæt og motion.
Reproduction is authorised provided the source is acknowledged. obese patients compared the effects of Xenical and placebo over four years, in combination with diet and exercise.
Reproduction is authorised provided the source is acknowledged. sygeplejerske.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. symptomer.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. syv dage kan dosis øges til 300 mg dagligt.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. så der kommer flere bakterier, der producerer propionsyre, som anvendes til dannelse af glukose.
Reproduction is authorised provided the source is acknowledged. rumen resulting in an increase of the bacteria that produce propionate, a substance used to make glucose.
Reproduction is authorised provided the source is acknowledged. såsom hydrochlorthiazid, kan anvendes som tillægsbehandling.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. sædvanligvis inden for tre til fem måneder.
This is usually reached within three to five months.
Reproduction is authorised provided the source is acknowledged. til 80 mg, eller der kan anvendes andre lægemidler mod forhøjet blodtryk såsom hydrochlorothiazid, som tillægsbehandling.
Reproduction is authorised provided the source is acknowledged. dose can be increased to 80 mg, or another medicine for hypertension can be added, such as hydrochlorothiazide.
Reproduction is authorised provided the source is acknowledged. til at behandle vedvarende neutropeni hos patienter med fremskreden hiv-infektion for at reducere risikoen for bakterielle infektioner, når andre behandlingsmuligheder ikke er hensigtsmæssige.
Reproduction is authorised provided the source is acknowledged. to treat persistent neutropenia in patients with advanced human immunodeficiency virus (HIV) infection, to reduce the risk of bacterial infections when other treatments are not appropriate.
Reproduction is authorised provided the source is acknowledged. til at mindske behovet for blodtransfusioner hos voksne med moderat anæmi, som skal have foretaget større ortopædkirurgiske indgreb såsom en hofteoperation.
Reproduction is authorised provided the source is acknowledged. to reduce the need for blood transfusions in adults with moderate anaemia who are about to undergo major orthopaedic (bone) surgery, such as hip surgery.
Reproduction is authorised provided the source is acknowledged. til behandling af infektioner med visse rundorme (nærmere angivet i indlægssedlen) i mave- tarmsystemet hos katte og hunde.
Reproduction is authorised provided the source is acknowledged. for the treatment of infections with certain (as specified in the package leaflet) gastrointestinal roundworms in cats and dogs.
Reproduction is authorised provided the source is acknowledged. til behandling af vedvarende neutropeni hos patienter med fremskreden hiv-infektion for at reducere risikoen for bakterielle infektioner, når andre former for behandling ikke er egnede.
Reproduction is authorised provided the source is acknowledged. to treat persistent neutropenia in patients with advanced human immunodeficiency virus (HIV) infection, to reduce the risk of bacterial infections when other treatments are not appropriate.
Reproduction is authorised provided the source is acknowledged. til får og kvæg, registrerer dyrenes immunsystem virussene som "fremmede" og reagerer ved at danne antistoffer imod dem.
Reproduction is authorised provided the source is acknowledged. animals’ immune system recognises the viruses as ‘foreign’ and makes antibodies against them.
Reproduction is authorised provided the source is acknowledged. tillægsbehandling til metformin.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. tre-ugers behandlingsfri periode.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. tredje uge.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. type bivirkninger opstår.
Reproduction is authorised provided the source is acknowledged. if certain side effects develop.
Reproduction is authorised provided the source is acknowledged. ud af cellerne, hvilket medfører ukontrolleret aktivitet i centralnervesystemet hos parasitterne, og at de dør.
Reproduction is authorised provided the source is acknowledged. which results in uncontrolled activity of the central nervous system and death of these parasites.
Reproduction is authorised provided the source is acknowledged. udgår fra hjernen.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. uge, indtil det er stabilt, og derefter med jævne mellemrum.
Reproduction is authorised provided the source is acknowledged. are stable, and then periodically.
Reproduction is authorised provided the source is acknowledged. under huden eller direkte i 18 dage gamle æg med ikke-udklækkede fostre under udvikling.
Reproduction is authorised provided the source is acknowledged. chicks).
Reproduction is authorised provided the source is acknowledged. vaccinerede kats blod.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. vandige væske (kammervand) ud af øjeæblet.
Reproduction is authorised provided the source is acknowledged. drainage of the watery fluid (aqueous humour) out of the eyeball.
Reproduction is authorised provided the source is acknowledged. vaskulære hændelser såsom hjerteanfald eller slagtilfælde, som ikke kan tage vitamin K- antagonister (andre lægemidler, der forebygger blodpropper), og som har en lille blødningsrisiko.
Reproduction is authorised provided the source is acknowledged. events such as a heart attack or stroke, cannot take vitamin K antagonists (other medicines that prevent blood clots) and are at low risk of bleeding.
Reproduction is authorised provided the source is acknowledged. virker ved at bindes til dabigatran og danne et kompleks i blodet.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. ændre kroppens hormonbalance og forhindre ægløsning ved at ændre den cervikale sekretion og gøre endometrium (livmodervæggen) tyndere.
Reproduction is authorised provided the source is acknowledged. the body’s hormonal balance to prevent ovulation, by altering the cervical mucus and by thinning the endometrium (the lining of the womb).
Reproduction is authorised provided the source is acknowledged. øger optagelsen af væsker og reducerer dermed diarré.
Reproduction is authorised provided the source is acknowledged. fluids and so reducing diarrhoea.
Reproduction is authorised provided the source is acknowledged. øges i trin på 1,5 mg med mindst to uger mellem hvert trin, indtil en fast dosis på 3 til 6 mg to gange dagligt er nået.
Reproduction is authorised provided the source is acknowledged. be increased in 1.5-mg steps no more frequently than every two weeks, to a regular dose of 3 to 6 mg twice a day.
Reproduction is authorised provided the source is acknowledged.edged
Reproduction is authorised provided the source is acknowledged.
Reproduktion
Developmental Toxicity
Reproduktion med kildehenvisning er tilladt.
Reproduction is authorised provided the source is acknowledged.
Reproduktions- og udviklingsstudier har vist en potent effekt på føtalt tab med en høj frekvens hos rotter og mus (henholdsvis 180 pg/ml og 30 pg/ml plasma) ved eksponering 1,2 til 6 gange den kliniske eksponering (op til 25 pg/ml).
Reproduction and development studies have demonstrated a potent effect on foetal loss with a high rate observed in rats and mice (180 pg/mL and 30 pg/mL plasma, respectively) at exposures 1.2 to 6 times the clinical exposure (up to 25 pg/mL).
Reproduktions-og udviklingsstudier har vist en potent effekt på føtalt tab med en høj frekvens hos rotter og mus (henholdsvis 180 pg/ml og 30 pg/ml plasma) ved eksponering 1,2 til 6 gange den kliniske eksponering (op til 25 pg/ml).
Reproduction and development studies have demonstrated a potent effect on foetal loss with a high rate observed in rats and mice (180 pg/ml and 30 pg/ml plasma, respectively) at exposures 1.2 to 6 times the clinical exposure (up to 25 pg/ml).
Reproduktions-toksicitetsstudier er blevet udført med travoprost på rotter, mus og kaniner ved systemisk indgivelse.
Reproduction toxicity studies with travoprost have been undertaken in rat, mice and rabbit by systemic route.
Reproduktionsdygtige kvinder skal rådes til at undgå graviditet under behandlingen med Cyramza og skal informeres om den potentielle risiko for graviditeten og fostret.
Women of childbearing potential should be advised to avoid becoming pregnant while on Cyramza and should be informed of the potential hazard to the pregnancy and foetus.
Reproduktionsdygtige kvinder/Kontraception hos kvinder
Women of childbearing potential/Contraception in females
Reproduktionsdygtige kvinder/Prævention for mænd og kvinder
Women of childbearing potential / Contraception in males and females
Reproduktionsstudie med dyr har ikke vist nogen forskelle mellem insulin degludec og humant insulin med hensyn til embryotoksicitet og teratogenicitet.
Animal reproduction studies have not revealed any difference between insulin degludec and human insulin regarding embryotoxicity and teratogenicity.
Reproduktionsstudie med insulin degludec hos dyr har ikke vist nogen bivirkninger på fertiliteten.
Animal reproduction studies with insulin degludec have not revealed any adverse effects on fertility.
Reproduktionsstudier er blevet udført på cynomolgusaber med doser, der er op til 25 gange højere end den humane ugentlige vedligeholdelsesdosis på 2 mg/kg intravenøst formuleret Herceptin, og har ikke vist tegn på nedsat fertilitet eller skader på fostret.
Reproduction studies have been conducted in Cynomolgus monkeys at doses up to 25 times that of the weekly human maintenance dose of 2 mg/kg Herceptin intravenous formulation and have revealed no evidence of impaired fertility or harm to the foetus.
Reproduktionsstudier i dyr har ikke vist nogen virkning på mandlig eller kvindelig fertilitet (se pkt.
Reproductive studies in animals have shown no effect on male or female fertility (see section
Reproduktionsstudier med insulin glulisin i dyr har ikke afdækket nogen skadelig effekt på fertilitet.
Animal reproduction studies with insulin glulisine have not revealed any adverse effects on fertility.
Reproduktionsstudier med rotter og kaniner indikerede ingen virkninger af agomelatin på fertilitet (se pkt.
Reproduction studies in the rat and the rabbit showed no effect of agomelatine on fertility (see section 5.3).
Reproduktionsstudier på dyr har ikke vist nogen forskelle mellem insulin glulisin og human insulin hvad angår graviditet, embryonal/føtal udvikling, fødsel eller postnatal udvikling (se pkt.
Animal reproduction studies have not revealed any differences between insulin glulisine and human insulin regarding pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3).
Reproduktionstoksicitet er set i dyrestudie (se Fertilitet).
Studies in animals have shown reproductive toxicity (see section 5.3).
Reproduktionstoksicitet:
Reproductive toxicity
Reproduktionstoksicitets studier blev udført på rotter (fertlitet og embryo-føtotoksicitet studie inkl. en fase med afkom) og på kaniner (embryo-føtotoksicitet studie, dose-range finding alene).
Reproductive toxicity studies were performed in rats (fertility and embryo-foetotoxicity study including a littering phase) and in rabbits (embryo-foetotoxicity study, dose-range finding only).
Reproduktionstoksicitetsstudier med timolol viste forsinket ossifikation hos rottefostre uden bivirkninger på den postnatale udvikling (ved 50 mg/kg/dag eller 3500 gange den daglige kliniske dosis på 14 /kg/dag) og øget fosterresorption hos kaniner (ved 90 mg/kg/dag eller 6400 gange den daglige kliniske dosis).
Reproduction toxicity studies with timolol showed delayed foetal ossification in rats with no adverse effects on postnatal development (at 50 mg/kg/day or 3500 times the daily clinical dose of 14 g/kg/day) and increased foetal resorptions in rabbits (at 90 mg/kg/day or 6400 times the daily clinical dose).
Reproduktionstoxicitets-studier foretaget med kombinationen har vist fototoxititet, der er foreneligt med estradioleksponering.
Reproductive toxicity studies performed with the combination have shown foetotoxicity which is consistent with estradiol exposure.
Reproduktionsundersøgelser i dyr har ikke vist tegn på teratogenese og viste ingen effekt på fertiliteten hos hverken hanner eller hunner.
Reproductive studies in animals have not shown evidence of teratogenicity and showed no effect on male or female fertility.
reproduktive
Liver function disorders§
reproduktive system og mammae
Reproductive system and breast disorder
reproduktive system og mammae
Reproductive system and breast disorders
Reproduktive toksicitetesforsøg med fesoterodin i dyr viser lettere embroyotoksicitet (se pkt.
Reproductive toxicity studies with fesoterodine in animals show minor embryotoxicity (see section 5.3).
Reproduktive toksikologi- studier med rHuPH20 viste embryo-føtal-toksicitet i mus ved høj systemisk eksponering, men viste ikke teratogent potentiale.
Reproductive toxicology studies with rHuPH20 revealed embryofetal toxicity in mice at high systemic exposure, but did not show teratogenic potential.
Repso 10 mg filmovertrukket tablet Repso 20 mg filmovertrukne tabletter
Repso 10 mg film-coated tablets Repso 20 mg film-coated tablets
Repso 10 mg filmovertrukne tabletter er hvide, runde filmovertrukne tabletter præget med “10” på den ene side og “L” på den anden.
Repso 10 mg film-coated tablets are white, round film-coated tablets, engraved with “10” on one side and “L” on the other.
Repso 10 mg tabletter leflunomid
Repso 10 mg tablets leflunomide
Repso 20 mg filmovertrukne tabletter er hvide, runde filmovertrukne tabletter præget med “10” på den ene side og “L” på den anden.
Repso 20 mg film-coated tablets are dark beige, triangle shaped, film-coated tablets, engraved with ”20” on one side and “L” on the other.
Repso 20 mg tabletter leflunomid
Repso 20 mg tablets leflunomide
Repso anbefales ikke til børn og unge under 18 år.
Repso is not recommended for use in children and adolescents below 18 years of age.
Repso bruges til at behandle voksne med aktiv reumatoid artrit eller med aktiv psoriasis artrit.
Repso is used to treat adult patients with active rheumatoid arthritis or with active psoriatic arthritis.
Repso er et ‘generisk lægemiddel’.
Repso is a ‘generic medicine’.
Repso’s udseende og pakningsstørrelse
What Repso looks like and contents of the pack
Research Triangle Park North Carolina
6051 George Watts Hill Drive Research Triangle Park
Reserveprøve af stamceller udtages
Backup sample of stem cells collected
RESET-undersøgelsen
RESET Study
resistens (dvs. hvis der
resistance (i.e. lack of
Resistens er usædvanlig hos Enterobacteriaceae, og ertapenem er generelt aktivt over for dem med udvidet spektrum betalaktamaser (ESBL).
Resistance is uncommon in Enterobacteriaceae and ertapenem is generally active against those with extended-spectrum beta-lactamases (ESBLs).
Resistens hos Mycoplasma hyopneumoniae og Lawsonia intracellularis over for tylvalosin er ikke rapporteret eller fundet i feltundersøgelser til dato.
Resistance to tylvalosin by Mycoplasma hyopneumoniae and Lawsonia intracellularis has not been reported or found in the field to date.
Resistens in vitro og in vivo (abacavir og lamivudin):
Resistance in vitro and in vivo: (abacavir and lamivudine)
Resistens kan imidlertid observeres, når ESBL eller andre potente betalaktamaser (f.eks.
Resistance can however be observed when ESBLs or other potent beta-lactamases (e.g.
Resistens kan også opstå via tilegnelse af betalaktamaser med signifikant carbapenem-hydrolyserende aktivitet (f.eks.
Resistance can also arise via the acquisition of betalactamases with significant carbapenem-hydrolysing activity (e.g.
Resistens kan være kromosomal eller plasmidkodet og kan blive overført, hvis den er forbundet med transposoner eller plasmider.
Resistance may be chromosomal or plasmid-encoded and may be transferred if associated with transposons or plasmids.
Resistens mod cephalosporiner er resultatet af enzymatisk inaktivering (beta-lactamase produktion), fra reduceret permeabilitet ved mutation af porer eller ændring i efflux, eller fra selektion af penicillinbindende proteiner med lav affinitet.
Resistance to cephalosporins results from enzymatic inactivation (-lactamase production) or from other mechanisms.
Resistens mod cephalosporiner er resultatet af enzymatisk inaktivering (β-lactamase produktion), fra reduceret permeabilitet ved mutation af porer eller ændring i efflux, eller fra selektion af penicillinbindende proteiner med lav affinitet.
Resistance to cephalosporins results from enzymatic inactivation (-lactamase production), from reduced permeability by porin mutations or change in efflux, or by selection of low-affinity penicillin-binding proteins.
Resistens mod fluorokinoloner sker ved kromosomal mutation via tre mekanismer: Mindsket permeabilitet i bakteriernes cellevæg, aktivering af effluxpumpe eller mutation af enzymer, der er ansvarlige for molekylets receptorbinding.
Resistance to fluoroquinolones occurs by chromosomal mutation with three mechanisms: Decrease of the bacterial wall permeability, expression of efflux pump, or mutation of enzymes responsible for the molecule’s binding site.
Resistens mod lopinavir, defineret som tilstedeværelse af enhver primær eller mutation i det aktive site i protease (se ovenfor), blev observeret hos 0/51 (0%) patienter.
Resistance to lopinavir, defined as the presence of any primary or active site mutations in protease (see above), was observed in 0/51 (0%) patients.
Resistens mod makrolider kan udvikles ved mutation i gener der koder for ribosomal RNA (rRNA) eller nogle ribosomal proteiner; ved enzymatisk modifikation (metylering) af det specifikke 23S rRNA, hvilket ofte giver krydsresistens med lincosamider og gruppe B-streptogramin (MLSB resistens); ved enzymatisk inaktivering eller ved macrolid efflux.
Resistance to macrolides can develop by mutations in genes encoding ribosomal RNA (rRNA) or some ribosomal proteins; by enzymatic modification (methylation) of the 23S rRNA target site, generally giving rise to cross-resistance with lincosamides and group B streptogramins (MLSB resistance); by enzymatic inactivation; or by macrolide efflux.
Resistens og specifikke forsigtighedsregler for lamivudin-refraktære patienter: Mutationer i den HBV- polymerase, der koder for lamivudin-resistens-substitutioner, kan forårsage sekundære substitutioner, inklusive entecavir-associerede resistens-substitutioner (ETVr).
Resistance and specific precaution for lamivudine-refractory patients: mutations in the HBV polymerase that encode lamivudine-resistance substitutions may lead to the subsequent emergence of secondary substitutions, including those associated with entecavir associated resistance (ETVr).
Resistens og specifikke forsigtighedsregler for lamivudinrefraktære patienter: Mutationer i den HBV- polymerase, der koder for lamivudinresistenssubstitutioner, kan forårsage sekundære substitutioner, inklusive entecavir-associerede resistenssubstitutioner (ETVr).
Resistance and specific precaution for lamivudine-refractory patients: mutations in the HBV polymerase that encode lamivudine-resistance substitutions may lead to the subsequent emergence of secondary substitutions, including those associated with entecavir associated resistance (ETVr).
resistens over for atazanavir.
development of resistance to
Resistens over for dalbavancin hos Staphylococcus spp. og Enterococcus spp. forårsages af VanA, en genotype, som medfører en modifikation i målpeptidet i den nye cellevæg.
Resistance to dalbavancin in Staphylococcus spp. and Enterococcus spp. is mediated by VanA, a genotype that results in modification of the target peptide in nascent cell wall.
Resistens over for delamanid er forekommet under behandling.
Resistance to delamanid has occurred during treatment.